Vancouver researchers urge caution with combinations of lipid drugs
6 November 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Side effects
Three-year renal safety with tenofovir; cystatin may be a useful marker
6 September 2004. Related: Conference reports, Side effects.
Efficacy of acetyl-L-carnitine for antiretroviral toxic neuropathy
6 September 2004. Related: Side effects.
Oral uridine to treat mitochondrial toxicity
2 June 2004. Related: Side effects.
Phase II results show ThGRF could be safe, effective treatment for lipodystrophy, says company
2 June 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Reversibility of lipoatrophy in HIV patients 2 years after switching from a thymidine analogue to abacavir
2 June 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Diabetes and HIV and HCV; aging/HIV and diabetes
2 May 2004. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Eating grapefruit triggers statin-related rhabdomyolysis
2 May 2004. Related: PK and drug interactions, Side effects.
FDA panel recommends approval of New-fill
2 May 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Lipodystrophy regresses in three patients switched to atazanavir
2 May 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Race affects absorption and clearance of efavirenz
3 April 2004. Related: Conference reports, PK and drug interactions, Side effects.
Update on peripheral neuropathy in HIV-infection
3 April 2004. Related: Conference reports, Side effects.
Smoking marijuana provides analgesic effect on HIV neuropathy
3 April 2004. Related: Conference reports, Side effects.
Two D:A:D updates: cardiovascular risk from HAART, and predictors of hypertension and changes in blood pressure
3 April 2004. Related: Conference reports, Side effects.
Low-dose rHGH maintains reductions in abdominal fat for 60 weeks
3 April 2004. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Rosiglitazone shows no benefit for lipoatrophy
2 April 2004. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Importance of dietary management in treating lipid disorders: soy diets may offer comparable effect as statins
3 February 2004. Related: Side effects, Lipodystrophy and metabolic complications.
Lower doses of d4T produce similar efficacy and reduced side effects
1 December 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Switching from efavirenz to nevirapine to avoid CNS side effects
1 December 2003. Related: Conference reports, Antiretrovirals, Side effects.
Intrauterine exposure to efavirenz
1 December 2003. Related: Conference reports, Women's health, Pregnancy, Side effects.
Increased risk of myocardial infarction associated with duration of protease inhibitor treatment
1 December 2003. Related: Side effects.
Newer nucleoside analogues show fewer adverse effects
1 November 2003. Related: Conference reports, Side effects.
Testosterone therapy prevents loss of lean body mass, improves mood and libido in HIV positive women and increases bone mineral density in HIV positive men
1 October 2003. Related: Side effects.
Only time with HIV infection and not specific antiretroviral therapy is associated with decreased bone mineral density
1 October 2003. Related: Side effects.
Rosiglitazone with insulin resistance
1 September 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Uridine treatment for mitochondrial toxicity
1 September 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Severe efavirenz psychotic events
1 September 2003. Related: Conference reports, Side effects.
Uridine as a potential treatment for NRTI related mitochondrial toxicity
1 September 2003. Related: Conference reports, PK and drug interactions, Side effects.
Long term exposure to nucleoside analogues and peripheral nerve function
1 September 2003. Related: Conference reports, Side effects.
Step-wise intervention eases diarrhoea linked to PI nelfinavir (Viracept) therapy
1 September 2003. Related: Conference reports, Antiretrovirals, Side effects.
Bone mineral metabolism and HIV-infection
1 September 2003. Related: Side effects.
FDA says some follow-up drug studies are never started
1 July 2003. Related: Side effects.
Lamotrigine shows some benefit for HIV-associated painful sensory neuropathies
1 July 2003. Related: Side effects.
Women: sexual function and relationships
1 June 2003. Related: Conference reports, Women's health, Side effects.
High levels of gout may be linked to HAART
1 June 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Tenofovir side effects
1 June 2003. Related: Side effects.
HIV-positive patients sustain acute myocardial infarction at a young age and have a benign in-hospital course
1 June 2003. Related: Side effects.
Cardiovascular and cerebrovascular events in patients treated for HIV infection
1 June 2003. Related: Side effects.
Severe hepatotoxicity during ART: incidence, liver histology, and outcome
1 June 2003. Related: Side effects.
Peripheral neuropathy in HIV disease: Lactate levels may help determine if nucleoside toxicity is a contributing factor
1 June 2003. Related: Side effects.
Less diarrhoea and bioequivalence with the new nelfinavir 625mg tablet
1 May 2003. Related: Conference reports, Antiretrovirals, PK and drug interactions, Side effects.
The potential for probenecid to have a serious interaction with HIV-1 protease inhibitors
1 May 2003. Related: Conference reports, PK and drug interactions, Side effects.
Tenofovir and renal tubular dysfunction
1 April 2003. Related: Conference reports, Side effects.
Approaches to treatment of lipodystrophy
1 April 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Surgery for buffalo hump shows variable results depending on method
1 April 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Other studies – nucleosides and switching to abacavir; importance of lipoatrophy and buffalo hump
1 April 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
HAART to HEART: cardiovascular risk in HIV
1 April 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Alendronate, vitamin D and calcium are safe and effective treatment for HIV-associated bone loss
1 April 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Bone loss and fat loss are closely related in HIV patients on HAART
1 April 2003. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Pegylated interferon associated with eye disorders
1 April 2003. Related: Conference reports, Side effects, Hepatitis coinfection.
Efavirenz effects worse than reported, study says
1 March 2003. Related: Side effects.
Protease inhibitors and cardiovascular outcomes in patients with HIV-1
1 March 2003. Related: Side effects, Lipodystrophy and metabolic complications.
HIV protease inhibitors promote atherosclerosis independent of dyslipidemia
1 March 2003. Related: Side effects, Lipodystrophy and metabolic complications.
Comparison of the efficacy and safety of tenofovir vs. d4T when used in combination with 3TC and efavirenz in ARV-naive patients
1 February 2003. Related: Conference reports, Antiretrovirals, Side effects, Lipodystrophy and metabolic complications.
Safety profile of tenofovir in treatment-experienced patients
1 February 2003. Related: Conference reports, Antiretrovirals, Side effects.
Perspectives on hormonal, mitochondrial and metabolic changes
1 December 2002. Related: Side effects, Lipodystrophy and metabolic complications.
IAS panel issues first guidelines for HIV and HIV drug-related metabolic complications (2002)
1 December 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Side effects are a common cause of intentional non adherence to HAART
1 December 2002. Related: Side effects.
Adverse drug reactions and lipodystrophy in children
13 November 2002. Related: Conference reports, Paediatric care, Side effects.
Lipodystrophy and adverse drug reaction data presented at the 42nd ICAAC
13 November 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
A range of treatments for facial lipoatrophy
13 November 2002. Related: Conference reports, Side effects, Lipodystrophy and metabolic complications.
Tamoxifen for male breast enlargement?
13 November 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Diet can help reduce lipid levels in people with HAART-related dyslipemia
13 November 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Lipodystrophy syndrome and self-assessment of wellbeing and physical appearance in HIV-positive patients
1 November 2002. Related: Side effects, Lipodystrophy and metabolic complications.
Abacavir hypersensitivity reactions in patients who rechallenge after interruptions for reasons other than hypersensitivity
11 September 2002. Related: Conference reports, Side effects.